NASDAQ: TLSI
Trisalus Life Sciences Inc Stock Ownership - Who owns Trisalus Life Sciences?

Insider buying vs selling

Have Trisalus Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mary T. SzelaCEO and President2026-03-1715,944$3.85
$61.38kSell
Bryan F. CoxChief of Research2026-03-16579$4.12
$2.39kSell
Jodi DevlinChief of Clinical Operations2026-03-16273$4.12
$1.12kSell
Jennifer StevensChief Regulatory Officer2026-03-16774$4.12
$3.19kSell
Richard MarshakChief Commercial Officer2026-03-16419$4.12
$1.73kSell
Richard MarshakChief Commercial Officer2026-03-121,589$4.09
$6.50kSell
Bryan F. CoxChief of Research2026-03-121,467$4.09
$6.00kSell
Jodi DevlinChief of Clinical Operations2026-03-121,772$4.09
$7.25kSell
Jennifer StevensChief Regulatory Officer2026-03-121,552$4.09
$6.35kSell
Mary T. SzelaCEO and President2026-03-114,358$4.13
$18.00kSell

1 of 3

TLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TLSI insiders and whales buy or sell their stock.

TLSI Shareholders

What type of owners hold Trisalus Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medtech Acquisition Sponsor LLC10.19%6,249,999$24.50MInsider
Equity Ab Frankenius10.16%6,230,748$24.42MInsider
Mats Wahlstrom4.35%2,665,202$10.45MInsider
Kerry R. Hicks3.73%2,289,199$8.97MInsider
Nantahala Capital Management LLC3.38%2,070,827$8.12MInstitution
Blackrock Inc2.50%1,534,336$6.01MInstitution
Vanguard Group Inc2.50%1,530,707$6.00MInstitution
Awm Investment Company Inc2.03%1,243,780$4.88MInstitution
Michael P. Stansky1.61%986,830$3.87MInsider
Gilder Gagnon Howe Co LLC1.60%979,023$3.84MInstitution

1 of 3

TLSI vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLSI18.64%36.67%Net BuyingNet Buying
CVRX41.08%58.92%Net BuyingNet Buying
PROF41.99%1.62%Net Buying
MASS54.72%45.28%Net SellingNet Selling
RXST74.19%25.81%Net BuyingNet Selling

Trisalus Life Sciences Stock Ownership FAQ

Who owns Trisalus Life Sciences?

Trisalus Life Sciences (NASDAQ: TLSI) is owned by 18.64% institutional shareholders, 36.67% Trisalus Life Sciences insiders, and 44.69% retail investors. Medtech Acquisition Sponsor LLC is the largest individual Trisalus Life Sciences shareholder, owning 6.25M shares representing 10.19% of the company. Medtech Acquisition Sponsor LLC's Trisalus Life Sciences shares are currently valued at $24.06M.

If you're new to stock investing, here's how to buy Trisalus Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.